News | March 28, 2011

SNM Enhances Education Program for 2011 Annual Meeting

March 28, 2011 – The Society of Nuclear Medicine’s (SNM) 2011 Annual Meeting, June 4-8 in San Antonio, offers a variety of new education options to nuclear medicine and molecular imaging professionals. With new topics, formats and technologies, the meeting provides a comprehensive review of the latest research and issues in the field.

"In planning the education offerings for the annual meeting, we look to provide attendees with programming that will increase their professional effectiveness, allowing them to examine and evaluate future directions in nuclear medicine, molecular imaging and therapy from both research and clinical perspectives,” said Peter Herscovitch, M.D., chair of SNM’s scientific program committee. “The program combines the latest advances in basic sciences with state of the art reviews of oncology, cardiology and neurology applications."

This year, new topics at SNM include healthcare reform, the future of nuclear medicine from the physicians’ perspective, an update on radioimmunotherapy and use of generator-produced Ga-68. Three hybrid sessions — featuring a mix of basic science, translational and clinical approaches — will be presented on breast cancer, neuroimaging and infection.

In addition, SNM will host several courses on dose reduction and radiation safety. Continuing education courses developed by SNM include those on pediatric dose reduction, reducing patient radiation exposure while improving diagnostic testing, standards of excellence and more.

For the first time, SNM will host a Nuclear Cardiology Technology workshop. There will also be six integrated scientific sessions — sessions that combine abstract presentations with a featured guest speaker. Self-assessment modules for the maintenance of certification program will be back as well.

During the plenary sessions, questions will be taken via text message and Twitter. Also new, SNM will capture 70 sessions and post them online as a virtual meeting available afterwards. The virtual meeting, with pre-meeting, on-site and post-meeting pricing, will include 35 continuing education sessions, 20 technologist sessions and 15 scientific sessions.

"SNM strives improve its content each year, adapting to the changing needs of nuclear medicine and molecular imaging professionals," said Herscovitch. "We have a strong program this year and look forward to a successful meeting."

The SNM Annual Meeting is the foremost educational and networking event in molecular imaging and nuclear medicine. The meeting attracts more than 5,000 scientists, physicians, pharmacists and technologists in the molecular imaging and nuclear medicine fields.

Attendees can choose full meeting registration or a weekend-only registration. Registration is required to receive credit for attending the sessions.

For more information: www.snm.org/am2011

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
Overlay Init